CVS Health (CVS) stock is in focus as the firm settles FTC allegations that its drug benefit manager, Caremark, artificially inflated insulin prices. Read more here.
CVS Health settles FTC case over insulin pricing
CVS Health (CVS) stock is in focus as the firm settles FTC allegations that its drug benefit manager, Caremark, artificially inflated insulin prices. Read more here.